Logo image of INFN

INFINERA CORP (INFN) Stock Fundamental Analysis

NASDAQ:INFN - Nasdaq - US45667G1031 - Common Stock - Currency: USD

6.64  -0.01 (-0.15%)

After market: 6.65 +0.01 (+0.15%)

Fundamental Rating

2

Overall INFN gets a fundamental rating of 2 out of 10. We evaluated INFN against 48 industry peers in the Communications Equipment industry. Both the profitability and financial health of INFN have multiple concerns. INFN has a decent growth rate and is not valued too expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

INFN had negative earnings in the past year.
In the past year INFN had a positive cash flow from operations.
In the past 5 years INFN always reported negative net income.
In multiple years INFN reported negative operating cash flow during the last 5 years.
INFN Yearly Net Income VS EBIT VS OCF VS FCFINFN Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M -100M -200M -300M

1.2 Ratios

INFN has a worse Return On Assets (-9.80%) than 62.75% of its industry peers.
With a Return On Equity value of -129.03%, INFN is not doing good in the industry: 78.43% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA -9.8%
ROE -129.03%
ROIC N/A
ROA(3y)-5.29%
ROA(5y)-7.71%
ROE(3y)-61%
ROE(5y)-56.84%
ROIC(3y)N/A
ROIC(5y)N/A
INFN Yearly ROA, ROE, ROICINFN Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -20 -40 -60 -80 -100

1.3 Margins

INFN has a Gross Margin of 38.43%. This is comparable to the rest of the industry: INFN outperforms 49.02% of its industry peers.
INFN's Gross Margin has improved in the last couple of years.
INFN does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 38.43%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y3.12%
GM growth 5Y5.37%
INFN Yearly Profit, Operating, Gross MarginsINFN Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40

More info and screens

1

2. Health

2.1 Basic Checks

INFN does not have a ROIC to compare to the WACC, probably because it is not profitable.
INFN has more shares outstanding than it did 1 year ago.
INFN has more shares outstanding than it did 5 years ago.
The debt/assets ratio for INFN is higher compared to a year ago.
INFN Yearly Shares OutstandingINFN Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M
INFN Yearly Total Debt VS Total AssetsINFN Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B

2.2 Solvency

INFN has an Altman-Z score of 0.01. This is a bad value and indicates that INFN is not financially healthy and even has some risk of bankruptcy.
INFN has a worse Altman-Z score (0.01) than 68.63% of its industry peers.
INFN has a debt to FCF ratio of 117.95. This is a negative value and a sign of low solvency as INFN would need 117.95 years to pay back of all of its debts.
INFN has a Debt to FCF ratio (117.95) which is comparable to the rest of the industry.
INFN has a Debt/Equity ratio of 5.73. This is a high value indicating a heavy dependency on external financing.
INFN has a Debt to Equity ratio of 5.73. This is amonst the worse of the industry: INFN underperforms 92.16% of its industry peers.
Industry RankSector Rank
Debt/Equity 5.73
Debt/FCF 117.95
Altman-Z 0.01
ROIC/WACCN/A
WACC8.48%
INFN Yearly LT Debt VS Equity VS FCFINFN Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M 600M

2.3 Liquidity

A Current Ratio of 1.51 indicates that INFN should not have too much problems paying its short term obligations.
With a Current ratio value of 1.51, INFN is not doing good in the industry: 66.67% of the companies in the same industry are doing better.
INFN has a Quick Ratio of 1.02. This is a normal value and indicates that INFN is financially healthy and should not expect problems in meeting its short term obligations.
The Quick ratio of INFN (1.02) is worse than 70.59% of its industry peers.
Industry RankSector Rank
Current Ratio 1.51
Quick Ratio 1.02
INFN Yearly Current Assets VS Current LiabilitesINFN Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

More info and screens

4

3. Growth

3.1 Past

INFN shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -457.37%.
INFN shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -12.12%.
INFN shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 1.78% yearly.
EPS 1Y (TTM)-457.37%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-298.93%
Revenue 1Y (TTM)-12.12%
Revenue growth 3Y-0.16%
Revenue growth 5Y1.78%
Sales Q2Q%-8.62%

3.2 Future

INFN is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 151.08% yearly.
Based on estimates for the next years, INFN will show a quite strong growth in Revenue. The Revenue will grow by 11.20% on average per year.
EPS Next Y326.09%
EPS Next 2Y151.08%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year13.51%
Revenue Next 2Y11.2%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
INFN Yearly Revenue VS EstimatesINFN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 500M 1B 1.5B
INFN Yearly EPS VS EstimatesINFN Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0 0.5 -0.5

More info and screens

4

4. Valuation

4.1 Price/Earnings Ratio

INFN reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Based on the Price/Forward Earnings ratio of 25.04, the valuation of INFN can be described as expensive.
INFN's Price/Forward Earnings is on the same level as the industry average.
The average S&P500 Price/Forward Earnings ratio is at 37.67. INFN is valued slightly cheaper when compared to this.
Industry RankSector Rank
PE N/A
Fwd PE 25.04
INFN Price Earnings VS Forward Price EarningsINFN Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 -10 20 30

4.2 Price Multiples

The rest of the industry has a similar Enterprise Value to EBITDA ratio as INFN.
The rest of the industry has a similar Price/Free Cash Flow ratio as INFN.
Industry RankSector Rank
P/FCF 278.85
EV/EBITDA 324.21
INFN Per share dataINFN EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as INFN's earnings are expected to grow with 151.08% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y151.08%
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

INFN does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

INFINERA CORP

NASDAQ:INFN (2/27/2025, 8:00:01 PM)

After market: 6.65 +0.01 (+0.15%)

6.64

-0.01 (-0.15%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupTechnology Hardware & Equipment
GICS IndustryCommunications Equipment
Earnings (Last)02-20 2025-02-20/amc
Earnings (Next)04-29 2025-04-29/amc
Inst Owners93.07%
Inst Owner Change-0.56%
Ins Owners1.39%
Ins Owner Change-10.6%
Market Cap1.58B
Analysts48
Price Target6.48 (-2.41%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-7.22%
Min Revenue beat(2)-13.76%
Max Revenue beat(2)-0.69%
Revenue beat(4)1
Avg Revenue beat(4)-5.96%
Min Revenue beat(4)-13.76%
Max Revenue beat(4)1.3%
Revenue beat(8)4
Avg Revenue beat(8)-3.07%
Revenue beat(12)6
Avg Revenue beat(12)-1.9%
Revenue beat(16)7
Avg Revenue beat(16)-1.81%
PT rev (1m)-1.16%
PT rev (3m)-1.16%
EPS NQ rev (1m)-50%
EPS NQ rev (3m)-50%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)-1.32%
Revenue NQ rev (3m)-1.32%
Revenue NY rev (1m)2.86%
Revenue NY rev (3m)2.86%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 25.04
P/S 1.11
P/FCF 278.85
P/OCF 19.59
P/B 13.56
P/tB N/A
EV/EBITDA 324.21
EPS(TTM)-0.64
EYN/A
EPS(NY)0.27
Fwd EY3.99%
FCF(TTM)0.02
FCFY0.36%
OCF(TTM)0.34
OCFY5.11%
SpS5.96
BVpS0.49
TBVpS-0.52
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -9.8%
ROE -129.03%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 38.43%
FCFM 0.4%
ROA(3y)-5.29%
ROA(5y)-7.71%
ROE(3y)-61%
ROE(5y)-56.84%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y3.12%
GM growth 5Y5.37%
F-Score2
Asset Turnover0.92
Health
Industry RankSector Rank
Debt/Equity 5.73
Debt/FCF 117.95
Debt/EBITDA 102.98
Cap/Depr 120.34%
Cap/Sales 5.29%
Interest Coverage N/A
Cash Conversion 1243.91%
Profit Quality N/A
Current Ratio 1.51
Quick Ratio 1.02
Altman-Z 0.01
F-Score2
WACC8.48%
ROIC/WACCN/A
Cap/Depr(3y)84.82%
Cap/Depr(5y)68.59%
Cap/Sales(3y)4.03%
Cap/Sales(5y)3.57%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-457.37%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-298.93%
EPS Next Y326.09%
EPS Next 2Y151.08%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-12.12%
Revenue growth 3Y-0.16%
Revenue growth 5Y1.78%
Sales Q2Q%-8.62%
Revenue Next Year13.51%
Revenue Next 2Y11.2%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-1485.78%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year854.17%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y144.26%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y62.96%
OCF growth 3Y42.13%
OCF growth 5YN/A